bpc 157 for degenerative disc diseas BPC-157 Peptide Therapy 101: Can BPC-157

Adding cagrilintide to tirzepatide Theoretical protocol (not clinically studied): If on tirzepatide 10-15mg: Stable on tirzepatide for 4+ weeks Continue tirzepatide at current dose Add cagrilintide 0.6mg weekly Standard cagrilintide titration to 2.4mg Rationale: Tirzepatide is dual GIP/GLP-1 (very powerful alone) Adding amylin pathway could theoretically enhance No clinical data on this combination Uncertain if additional benefit over tirzepatide alone Concerns: GI side effects may be severe (both slow gastric emptying) Tirzepatide already produces 15-22% weight loss alone Unclear if cagrilintide adds meaningful benefit Expensive combination Verdict: Wait for clinical data

Lyle: Oh yeah, I didnt use it all the time

At our center, before receiving the Hangover IV therapy, you will be asked to list your chronic illnesses, allergies (if any), and prescription medications

Additionally, we assist in navigating insurance options to potentially cover medically necessary treatments

If it is more than 5 days, skip the dose and take the next one on your regularly scheduled day

BPC 157 also has an effect on blood vessels, resulting in vessel recruitment that circumvents vessel occlusion and the development of additional shunting and rapid bypass loops to rapidly reestablish the integrity of blood flow (ischemic/reperfusion colitis, duodenal lesions, cecal perforation, and inferior vena caval occlusion)